Comments
Drug firm Aarti Drugs on Monday reported a 10.45 per cent dip in its consolidated net profit to Rs 20.89 crore for the quarter ended December 31, 2018.
The company had posted a net profit of Rs 23.33 crore for the corresponding period of the previous fiscal, Aarti Drugs said in a filing to BSE.
Consolidated revenue from operations of the company however stood at Rs 380.11 crore for the quarter under consideration as against Rs 335.41 crore for October-December 2017.
Shares of Aarti Drugs closed at Rs 592.70 on BSE, up 1.50 per cent from the previous close.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.